Natural Immune Modulator Supports the Health of Allergy Sufferers

By CP Staff

A clinical trial investigated the effect of EpiCor^® on symptoms of allergic rhinitis (hay fever).

Researchers supplemented 96 healthy subjects who had a history of allergic rhinitis with an oral, 500 mg daily dose of a modified fermentation product of Saccharomyces cerevisiae (EpiCor) or placebo for 12 weeks during the period of highest recorded total pollen counts for the geographic area. The subjects were evaluated at 6 and 12 weeks for allergic rhinitis symptoms, quality of life and levels of immunoglobulins in the saliva to measure the immune response.

The results showed that EpiCor significantly decreased the severity of allergic rhinitis symptoms. There was a significant decrease in nasal congestion and rhinorrhea (runny nose) and a slight improvement in discharge from the eyes. In addition, the group receiving EpiCor reported 12.5 fewer days with nasal congestion compared to the placebo group. Furthermore, the EpiCor group had significantly increased levels of salivary IgA, which protects the mucosal lining from pathogens and is important for an optimal immune response.

The researchers concluded, “This yeast-derived product appeared to be safe and efficacious, and should receive more clinical research with and without standard medications to reduce the impact of seasonal allergies, especially allergic rhinitis-induced nasal congestion.”

Reference:

Moyad MA, Robinson LE, Kittelsrud JM, Reeves SG, Weaver SE, Guzman AI, Bubak ME. Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial. Adv Ther. 2009;26(8):795-804.

The EpiCor available here at Complementary Prescriptions® is 100 percent pure without any fillers or flow agents.